06.04.2010 • News

Airgas Rejects Air Products' Tender Extension

Airgas on Thursday repeated its view that a $5.1 billion hostile bid by Air ProductsAir "grossly undervalues" the company, after larger rival Air Products earlier extended its tender offer for Airgas.

Air Products said its $60-per-share offer to Airgas will now expire at midnight on June 4. As of Thursday, about 12,291 shares of Airgas stock had been tendered, according to the statement from Air Products.

The Air Products' offer, made in February, was originally due to expire on April 9.

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

Top-Feature

most read

Photo
News • Chemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.